Genesis Genetics has appointed Tony Gordon to be laboratory director for its UK operations and vice president of its US operations. In his new roles, Gordon will sign off on all patient reports in the UK and will help expand the company's testing operations in the country.
Gordon joins Detroit-based Genesis Genetics from BlueGnome. Genesis Genetics relies on BlueGnome's 24sure array comparative genomic hybridization platform in its preimplantation genetic diagnostic services, according to its website.
Murali Prahalad has been named president and CEO of Epic Sciences, a La Jolla, Calif.-based company developing microfluidic chip-based tests that isolate and characterize circulating tumor cells.
Prahalad joins Epic from Life Technologies, where he was vice president of corporate strategy. He also served as vice president of business development at Sequenom and as an analyst for Gemini Consulting in Tokyo.
In addition to English, Prahalad speaks Japanese, French, and Kannada, a language spoken in India, Epic said.
Prahalad holds a PhD in biochemistry and molecular pharmacology from Harvard University, and a BSc in cellular and molecular biology from the University of Michigan.